Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > 1.7 mil shares traded (1/2 day) / $US OTC BVAXF 800k~ .065
View:
Post by frankman on Dec 20, 2024 12:24pm

1.7 mil shares traded (1/2 day) / $US OTC BVAXF 800k~ .065

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr
ATS 43.0 0.06 · 0.065 404.5 0.065 +0.005 8.3 848.4 50 52
CSE - C 43.0 0.06 · 0.065 404.5 0.065 +0.005 8.3 463.0 27 24
NEO ATS - U   0.06     2.0 0 1
Omega - O   0.06     226.0 14 14
CX2 - H   0.06     131.0 8 9
CXD - D   0.06     0.5   1
TriAct - M   0.06     25.9 1 3
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities